MONA GUPTA: Open Payments
NPI 1902923691 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,424 in 59 payments from 15 companies in 2025. Trend: 2023 $9,471 · 2024 $2,898 · 2025 $1,424
Food & beverage: $1,424
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 14 | $445 |
| ABBVIE INC. | 16 | $275 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $191 |
| Alkermes, Inc. | 4 | $95 |
| Axsome Therapeutics, Inc. | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Bausch Health US, LLC | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Almatica Pharma LLC | 2 | $32 |
Products named: SPRAVATO, VRAYLAR, CAPLYTA, Auvelity, ARISTADA, REXULTI, UZEDY, COBENFY.
Industry payments across NC — which companies pay providers there.
